CHM — Chimeric Therapeutics Share News
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- AU$0.16m
- -AU$0.64m
Australia Stock Exchange release from CHIMERIC THERAPE : Trading halt remains
Australia Stock Exchange release from CHIMERIC THERAPE : CDH17 CAR T PRECLINICAL DATA FEATURED IN NATURE CANCER
Brief: Chimeric Therapeutics Seeks Trading Halt
Australia Stock Exchange release from CHIMERIC THERAPE : Trading Halt
Australia Stock Exchange release from CHIMERIC THERAPE : Pause in Trading
Australia Stock Exchange release from CHIMERIC THERAPE : Completion of retail component of Entitlement Offer
Australia Stock Exchange release from CHIMERIC THERAPE : PRE_NR Ends: 09:59:20
Australia Stock Exchange release from CHIMERIC THERAPE : Security Class Suspension from Quotation CHMO
Australia Stock Exchange release from CHIMERIC THERAPE : Extension of Closing Date for Retail Entitlement Offer
Australia Stock Exchange release from CHIMERIC THERAPE : Appendix 3B (amended)
Australia Stock Exchange release from CHIMERIC THERAPE : PRE_NR Ends: 10:27:54
Australia Stock Exchange release from CHIMERIC THERAPE : Final Results in Phase 1 Trial of CORE NK Platform
Australia Stock Exchange release from CHIMERIC THERAPE : CORE NK Platform Phase 1 Clinical Data Presentation
Australia's Chimeric Therapeutics rises on deal with Be The Match BioTherapies
Australia Stock Exchange release from CHIMERIC THERAPE : CHIMERIC PARTNERS WITH BE THE MATCH BIOTHERAPIES
Australia Stock Exchange release from CHIMERIC THERAPE : PRE_NR Ends: 13:27:35
Australia Stock Exchange release from CHIMERIC THERAPE : Change in substantial holding - PH
Australia Stock Exchange release from CHIMERIC THERAPE : Change of Director's Interest Notice - PH
Australia Stock Exchange release from CHIMERIC THERAPE : Entitlement Offer Notice to Eligible Retail Shareholders